MacroGenics is pursuing alliances to participate in development of its proprietary product candidates and technology platforms.
Learn moreSince its founding in 2000, MacroGenics has applied its world-class antibody capabilities to create life-changing medicines. The company’s innovative product candidates leverage its fully-integrated capabilities and its multiple, proprietary technology platforms.
Learn more 2005 News Archive
April 24, 2005 | nature.com
Development Of A Humanized Monoclonal Antibody With Therapeutic Potential Against West Nile Virus
February 09, 2005 | PNAS.org
Selective Blockade Of Inhibitory Fc Receptor Enables Human Dendritic Cell Maturation With IL-12p70 Production And Immunity To Antibody-Coated Tumor Cells
News Archive: 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | View All